Clinical Trials Week articles

Recent articles from Clinical Trials Week

ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease.(Clinical report)
June 22, 2009... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced positive results from a proof-of-concept Phase 2 clinical study in subjects with dry eye disease (keratoconjuctivitis sicca) using a new, proprietary, low-dose formulation of bromfenac, the active ingredient in Xibrom(R) (bromfenac...

Researchers from Washington University, Medical Department report recent findings in breast cancer.
June 22, 2009... According to a study from the United States, "Neoadjuvant aromatase Inhibitor therapy has been reported to improve Surgical Outcomes for postmenopausal women with clinical stage II or III hormone receptor-positive breast cancer. A multicenter phase II clinical trial was conducted to...

Findings from F. Niazi and co-authors broaden understanding of cancer.
June 22, 2009... According to recent research published in the International Journal of Oncology, "Auron-Misheil-Therapy (AMT) consisting of aqueous camomile extract supplemented with calcium, vitamins, the antihistamine chlorpheniramine and human insulin is under development as anti-cancer treatment. AMT was...

Reports from Miguel Hernandez University advance knowledge in cancer.
June 22, 2009... "To characterize the population pharmacokinetics of plitidepsin (Aplidin(A (R))) in cancer patients. A total of 283 patients (552 cycles) receiving intravenous plitidepsin as monotherapy at doses ranging from 0.13 to 8.0 mg/m(2) and given as 1- or 24-h infusions every week; 3- or 24-h...

Research results from S. Servagivernat and co-authors update knowledge of cancer.(Clinical report)
June 22, 2009... "The number of elderly patients with oesophageal cancer is expected to increase with the aging of the population and the rapidly increasing incidence of adenocarcinoma. Surgical resection is standard treatment for patients with localized disease considered fit for operation," researchers in...